Geode Capital Management, LLC Oncternal Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.29 - $0.48 $17,504 - $28,973	60,361 Added 14.52%	475,945 $142,000
Q4 2022 Feb 13, 2023	BUY	$0.86 - $22.2 $5,145 - $132,822	5,983 Added 1.46%	415,584 $415,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.56 $284,917 - $634,959	-407,025 Reduced 49.84%	409,601 $454,000
Q1 2022 May 13, 2022	BUY	$1.37 - $2.43 $65,502 - $116,183	47,812 Added 6.22%	816,626 $1.14 Million
Q4 2021 Feb 11, 2022	BUY	$2.27 - $4.39 $14,448 - $27,942	6,365 Added 0.83%	768,814 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$3.37 - $4.76 $77,678 - $109,718	23,050 Added 3.12%	762,449 $3.18 Million
Q2 2021 Aug 13, 2021	BUY	$4.75 - $9.39 $1.78 Million - $3.53 Million	375,483 Added 103.18%	739,399 $3.51 Million
Q1 2021 May 12, 2021	BUY	$4.59 - $9.04 $1.01 Million - $1.99 Million	220,430 Added 153.62%	363,916 $3.03 Million
Q4 2020 Feb 12, 2021	BUY	$1.51 - $6.3 $187,702 - $783,127	124,306 Added 648.1%	143,486 $703,000
Q2 2020 Aug 13, 2020	BUY	$2.43 - $3.23 $3,419 - $4,544	1,407 Added 7.92%	19,180 $54,000
Q1 2020 May 14, 2020	BUY	$2.49 - $4.39 $1,927 - $3,397	774 Added 4.55%	17,773 $52,000
Q4 2019 Feb 13, 2020	BUY	$3.75 - $6.11 $10,736 - $17,492	2,863 Added 20.25%	16,999 $67,000
Q3 2019 Nov 12, 2019	SELL	$3.87 - $6.13 $23,390 - $37,049	-6,044 Reduced 29.95%	14,136 $70,000
Q2 2019 Aug 14, 2019	BUY	$4.86 - $9.24 $98,074 - $186,463	20,180 New	20,180 $134,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.